CMEI CovidF COVER1

NEW BRIEF: COVID-19 Restrictions Led to Small Health Benefits Negated by Tradeoff of Huge Economic, Education Losses

States that had more invasive COVID-19 restrictions saw small reductions in COVID-19 infection and mortality rates, but saw large negative impacts on employment, economic growth, and children’s education outcomes, finds a new brief released today by the Center for Medical Economics and Innovation at the nonpartisan Pacific Research Institute.CMEI_Covid_FINAL Click here to download the brief “Looking at the data, states with stricter COVID-19 public health policies did see small health benefits from reduced infections and
Survey

Read new PRI survey

Americans Satisfied with their Current Health Coverage, Lean Against Single Payer, Finds New PRI Survey

SACRAMENTO – A new national survey commissioned by the nonpartisan Pacific Research Institute, a California-based, free market think tank, finds that, for the second year in a row, an overwhelming majority of Americans are satisfied with their current health coverage. 90 percent of those surveyed said they were satisfied with their current health insurance plan, compared to 9 percent who said they were dissatisfied.  This represents a 4 percent increase in people’s satisfaction compared to
Health pexels artem podrez 8532824

Read about problems with drug price controls

Let’s Hope Drug Companies Win Price Controls War

The IRA gives federal officials the authority to dictate what Medicare pays for certain medicines — a scheme intended to reduce the government’s drug bill. Late last month, the Department of Health and Human Services announced the first 10 drugs subject to the law’s price controls, which include the blood thinners Eliquis and Xarelto. These price controls represent an unprecedented intervention in the market for prescription drugs that is likely to carry serious negative consequences for

Studies

CMEI CovidF COVER1
CoverageDeniedCoversforWeb8
CoverageDeniedCover7
340B Policy2022 F
CoverageDeniedCoversforWeb6
CACapital
BiosimilarsCompetition F Cover 2
CoverageDeniedCoversforWeb5
VapingStudy Finalweb cover
CoverageDeniedCoversforWeb 05
CoverageDeniedCoversforWeb 03
QuantifyingWrong Paper2 F Cover
Scroll to Top